Hospital Universitario Puerta de Hierro -ko ikertzaileekin lankidetzan egindako argitalpenak (55)

2023

  1. Adult T-cell leukemia/lymphoma in HTLV-1 non-endemic regions

    Journal of Clinical Virology, Vol. 167

  2. Coinfection with Viral Hepatitis in HIV patients in 2023

    AIDS reviews, Vol. 25, Núm. 1, pp. 65-66

  3. Genetic signature detected in T cell receptors from patients with severe COVID-19

    iScience, Vol. 26, Núm. 10

  4. Impact of potent nucleos(t)ide therapy on hepatitis B hospitalisations in Spain

    Alimentary Pharmacology and Therapeutics, Vol. 57, Núm. 5, pp. 540-548

  5. Safety considerations in the management of hepatitis C and HIV co-infection

    Expert Opinion on Drug Safety, Vol. 22, Núm. 5, pp. 363-372

  6. Treatment of hepatitis delta and HIV infection

    Liver International, Vol. 43, Núm. S1, pp. 108-115

  7. Viral hepatitis in persons living with HIV in the post-COVID era

    AIDS reviews, Vol. 25, Núm. 1, pp. 1-13

2021

  1. Envisioning a hepatitis delta cure with new antivirals

    Future Microbiology, Vol. 16, Núm. 13, pp. 927-930

  2. Main differences between the first and second waves of COVID-19 in Madrid, Spain

    International Journal of Infectious Diseases, Vol. 105, pp. 374-376

  3. Third wave of COVID-19 in Madrid, Spain

    International Journal of Infectious Diseases, Vol. 107, pp. 212-214

2020

  1. Advances in hepatitis B therapeutics

    Therapeutic Advances in Infectious Disease, Vol. 7

  2. COVID-19 comes 40 years after aids – Any lesson?

    AIDS Reviews, Vol. 22, Núm. 1, pp. 1-15

  3. Covid-19 comes 40 years after aids – any lesson?

    AIDS Reviews, Vol. 22, Núm. 2, pp. 63-77

  4. Long-acting antiretroviral therapy

    Nature Materials, Vol. 19, Núm. 8, pp. 826-827

2018

  1. Treatment and prevention of HIV infection with long-acting antiretrovirals

    Expert Review of Clinical Pharmacology, Vol. 11, Núm. 5, pp. 507-517